← Back to Search

Behavioural Intervention

Mindfulness Intervention for Post-COVID Syndrome

Waitlist Available
Led By Ivana Croghan, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.
Anyone that is not on a stable dose of medication for anxiety, depression or sleep.
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-baseline
Awards & highlights


This trial will study if using a brain sensing wellness device to learn meditation can help decrease stress and anxiety for post-Covid patients with lengthy symptoms.

Who is the study for?
This trial is for individuals who have had COVID-19 and are now experiencing long-term symptoms. Participants must not be pregnant, should have access to a smartphone or tablet, and be able to fully participate in the study. They should not have any health conditions that would affect using the Muse S™ headband and not be on unstable medication doses.Check my eligibility
What is being tested?
The trial is testing whether a wearable brain sensing device called Muse S™ can help reduce stress and anxiety in people with lingering post-Covid symptoms by teaching them meditation practices.See study design
What are the potential side effects?
While there may not be direct side effects from using the Muse S™ headband, participants might experience discomfort or frustration if they find it difficult to engage with mindfulness practices.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
I have been practicing mindfulness regularly for the past 3 weeks.
I am not on a stable dose of medication for anxiety, depression, or sleep.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reducing Anxiety
Reducing Stress

Trial Design

1Treatment groups
Experimental Treatment
Group I: Muse S™ Headband system for post-Covid SyndromeExperimental Treatment1 Intervention
Subjects will utilize the Muse S™ Headband system at least 4 times per week for a minimum of 10 minutes each time over a period of 3 months (12 weeks).

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Post-COVID Syndrome, particularly those targeting stress and anxiety, include mindfulness meditation, cognitive-behavioral therapy (CBT), and other stress-reduction techniques. Devices like the Muse-S, which aid in learning meditation, work by promoting relaxation and reducing the physiological stress response. This is important for Post-COVID Syndrome patients because chronic stress and anxiety can worsen symptoms such as fatigue, dyspnea, and cognitive impairments. Effective stress management can improve overall quality of life and potentially alleviate other persistent symptoms.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,255 Previous Clinical Trials
3,835,346 Total Patients Enrolled
Ivana Croghan, PhDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
23 Total Patients Enrolled
Ryan Hurt, MD, PhDStudy ChairMayo Clinic
4 Previous Clinical Trials
287 Total Patients Enrolled

Media Library

Muse S™ Headband system (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05199233 — N/A
Post-COVID Syndrome Research Study Groups: Muse S™ Headband system for post-Covid Syndrome
Post-COVID Syndrome Clinical Trial 2023: Muse S™ Headband system Highlights & Side Effects. Trial Name: NCT05199233 — N/A
Muse S™ Headband system (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05199233 — N/A
~19 spots leftby Jul 2025